Berman Capital Advisors’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$19K Sell
981
-27
-3% -$553 ﹤0.01% 997
2021
Q2
$20K Buy
1,008
+2
+0.2% +$43 ﹤0.01% 911
2021
Q1
$21K Buy
1,006
+2
+0.2% +$43 ﹤0.01% 776
2020
Q4
$21K Sell
1,004
-125
-11% -$2.44K 0.01% 660
2020
Q3
$19K Buy
1,129
+128
+13% +$2.38K 0.01% 603
2020
Q2
$18K Buy
1,001
+480
+92% +$8.5K ﹤0.01% 578
2020
Q1
$9K Sell
521
-16
-3% -$335 ﹤0.01% 697
2019
Q4
$11K Buy
537
+5
+0.9% +$101 ﹤0.01% 707
2019
Q3
$10K Sell
532
-25
-4% -$459 ﹤0.01% 718
2019
Q2
$9K Buy
+557
New +$10K ﹤0.01% 772

Other funds holding MPT

Berman Capital Advisors's MPT Position: Q3 2021 in Review

Berman Capital Advisors reduced its Medical Properties Trust (MPT) stake by 2.7% in Q3 2021, selling an estimated $553 and leaving 981 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Berman Capital Advisors first reported a position in MPT in Q2 2019 and has held it in 10 quarters since. The position peaked at $21K in Q1 2021. 564 funds tracked by Wall St. Rank hold MPT as of Q3 2021.

  • Berman Capital Advisors held 981 shares of Medical Properties Trust worth $19K as of Q3 2021.
  • Berman Capital Advisors sold 27 Medical Properties Trust shares in Q3 2021, an estimated $553.
  • Medical Properties Trust made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #997 holding.
  • Berman Capital Advisors first reported a position in Medical Properties Trust in Q2 2019 and has held it in 10 quarters since.
  • Berman Capital Advisors's Medical Properties Trust position peaked at $21K in Q1 2021.
  • 564 funds tracked by Wall St. Rank held Medical Properties Trust as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.